Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation

Matthew Laughon1, Michael T O'Shea, Elizabeth N Allred

  • 1Division of Neonatal-Perinatal Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7596, USA. matt_laughon@med.unc.edu

Pediatrics
|July 22, 2009
PubMed

Insights

Extremely low gestational age newborns (ELGANs) with chronic lung disease (CLD) did not show increased developmental delay risk when other factors were considered. However, severe CLD may still be linked to poorer psychomotor development in ELGANs.

Area of Science:

  • Neonatalogy
  • Developmental Pediatrics
  • Pulmonology

Background:

  • Extremely low gestational age newborns (ELGANs) face heightened risks for chronic lung disease (CLD) and developmental delays.
  • Existing research suggests a potential link between CLD and impaired neurodevelopment in ELGANs.

Purpose of the Study:

  • To investigate the association between CLD and developmental outcomes in ELGANs at 24 months corrected age.
  • To identify risk factors contributing to developmental delay in this vulnerable population.

Main Methods:

  • Prospective cohort study of 915 infants born before 28 weeks gestation.
  • Developmental assessment using Bayley Scales and Vineland Adaptive Behavior Scales at 24 months.
  • CLD defined by oxygen use at 36 weeks postmenstrual age; stratified by mechanical ventilation (MV) use.

Main Results:

  • 49% of ELGANs developed CLD, with 14% requiring MV.
  • After accounting for other risk factors, CLD (with or without MV) was not significantly associated with low Mental Developmental Index (MDI) or Psychomotor Developmental Index (PDI).
  • Severe CLD requiring MV showed a trend towards increased risk for low PDI, but did not reach statistical significance.

Conclusions:

  • The association between CLD and developmental delay in ELGANs appears mediated by other risk factors.
  • Once adjusted for confounding variables, CLD itself does not significantly increase the risk of low MDI or PDI.
  • Severe CLD may warrant closer monitoring for potential impacts on psychomotor development.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...